


芒果苷作用機制 - Medchemexpress - MCE中國.docx 免費下載
版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認(rèn)領(lǐng)
文檔簡介
1、Product Data SheetMangiferinCat. No.: HY-N0290CAS No.: 4773-96-0分式: CHO分量: 422.34作靶點: NF-B; Keap1-Nrf2; Apoptosis作通路: NF-B; Apoptosis儲存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實驗 DMSO : 50 mg/mL (118.39 mM; Need ultrasonic)SolventMass1 mg 5 mg 10 mgConcentration制備儲備
2、液1 mM 2.3678 mL 11.8388 mL 23.6776 mL5 mM 0.4736 mL 2.3678 mL 4.7355 mL10 mM 0.2368 mL 1.1839 mL 2.3678 mL請根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲備液;旦配成溶液,請分裝保存,避免反復(fù)凍融造成的產(chǎn)品失效。儲備液的保存式和期限:-80C, 6 months; -20C, 1 month。-80C 儲存時,請在 6 個內(nèi)使,-20C 儲存時,請在 1 個內(nèi)使。體內(nèi)實驗請根據(jù)您的實驗動物和給藥式選擇適當(dāng)?shù)娜芙獍浮R韵氯芙獍付颊埾劝凑?In Vitro 式配制澄清的儲備液,再依次添加助溶
3、劑:為保證實驗結(jié)果的可靠性,澄 的儲備液可以根據(jù)儲存條件,適當(dāng)保存;體內(nèi)實驗的作液,建議您現(xiàn)現(xiàn)配,當(dāng)天使; 以下溶劑前顯的百分 指該溶劑在您配制終溶液中的體積占;如在配制過程中出現(xiàn)沉淀、析出現(xiàn)象,可以通過加熱和/或超聲的式助溶1. 請依序添加每種溶劑: 10% DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (5.92 mM); Clear solution此案可獲得 2.5 mg/mL (5.92 mM,飽和度未知) 的澄清溶液。以 1 mL 作液為例,取 100 L 25.0 mg/mL 的澄 DMSO 儲備液加到 4
4、00 L PEG300 中,混合均勻;向上述體系中加50 L Tween-80,混合均勻;然后繼續(xù)加 450 L 理鹽定容 1 mL。2. 請依序添加每種溶劑: 10% DMSO 90% (20% SBE-CD in saline)Solubility: 2.5 mg/mL (5.92 mM); Clear solution此案可獲得 2.5 mg/mL (5.92 mM,飽和度未知) 的澄清溶液。Page 1 of 2 www.MedChemE以 1 mL 作液為例,取 100 L 25.0 mg/mL 的澄均勻。DMSO 儲備液加到 900 L 20% 的 SBE-CD 理鹽溶液中,混合3
5、. 請依序添加每種溶劑: 10% DMSO 90% corn oilSolubility: 2.5 mg/mL (5.92 mM); Clear solution此案可獲得 2.5 mg/mL (5.92 mM,飽和度未知) 的澄 溶液,此案不適于實驗周 期在半個以上的實驗。以 1 mL 作液為例,取 100 L 25.0 mg/mL 的澄 DMSO 儲備液加到 900 L 油中,混合均勻。BIOLOGICAL ACTIVITY物活性 Mangiferin種 Nrf2 激活劑。Mangiferin 抑制 NF-B 亞基p65 和 p50 的核移位。IC & Target p65 p50 Nrf
6、2體外研究 Mangiferin is glucosylxanthone extracted from plants of the Anacardiaceae and Gentianaceae families. Mangiferin (50M) significantly increases Nrf2 protein accumulation in HL-60 cells, particularly in the nucleus. Mangiferin alsoenhances the binding of Nrf2 to an antioxidant response element (A
7、RE), significantly up-regulates NAD(P)H:quinoneoxidoreductase 1 (NQO1) expression and reduces intracellular ROS in HL60 cells. Mangiferin alone dose-dependentlyinhibits the proliferation of HL-60 cells. In mononuclear cells (MNCs), Mangiferin significantly relieves oxidative stress,but attenuates et
8、oposide-induced cytotoxicity1. Mangiferin is a natural phytopolyphenol that exhibits variouspharmacological properties. Mangiferin is present in several plant species such as Mangifera indica, Iris unguicularis,and Anemarrhena asphodeloides. Mangiferin downregulates TNF-induced MMP-9 mRNA and protei
9、n expressionby suppressing NF-B activity, consequently suppressing the invasion of LNCaP cells.To assess whether Mangiferininfluences the viability of LNCaP cells, MTT assay is performed 24 h after treatment with different concentrations ofMangiferin in the presence or absence of TNF- in serum and s
10、erum-free conditions. There are no cytotoxic evidentin LNCaP cells treated with up to 400 M of Mangiferin alone under both serum and serum-free conditions.Additionally, in the presence of TNF- (20 ng/mL), Mangiferin does not affect cell viability. Mangiferin (400 M)treatment significantly decreases
11、the NF-B luciferase activity in TNF-stimulated LNCaP cells. Pretreatment withMangiferin (400 M) for 1 h significantly decreases TNF-induced NF-B activity. The RT-PCR shows that Mangiferin(400 M) significantly suppresses the TNF-induced MMP-9 expression in LNCaP cells2.PROTOCOLCell Assay 2 LNCaP cell
12、s are cultured at 37C in 5% CO2 in RPMI supplemented with 10% FBS and antibiotics. Cell viability isdetermined by an MTT assay. Briefly, LNCaP cells (1105 cells/mL) are plated onto 24 well plates and incubatedovernight in serum and serum-free RPMI media. The cells are treated with the indicated conc
13、entrations of Mangiferin(100, 200, and 400 M) for 1 h and then stimulated with TNF- (20 ng/mL) for 24 h. Then, the cells are incubatedwith a solution of 0.5 mg/mL MTT and incubation for 45 min at 37C and 5% CO2. Supernatant is removed and theformation of formazan is observed by monitoring the signal
14、 at 540 nm using a microplate reader2.MCE has not independently confirmed the accuracy of these methods. They are for reference only.戶使本產(chǎn)品發(fā)表的科研獻 Biochem Biophys Res Commun. 2018 Sep 3;503(1):297-303.See more customer validations on HYPERLINK www.MedChemE www.MedChemEPage 2 of 3 www.MedChemEREFERENCE
15、S1. Zhang BP, et al. Mangiferin activates Nrf2-antioxidant response element signaling without reducing the sensitivity to etoposide of human myeloidleukemia cells in vitro. Acta Pharmacol Sin. 2014 Feb;35(2):257-66.2. Dilshara MG, et al. Mangiferin inhibits tumor necrosis factor-induced matrix metalloproteinase-9 expression and cellular invasion by suppressingnuclear factor-B activity. BMB Rep. 2015 Oct;48(10
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025-2030中國手機零售行業(yè)消費狀況及競爭策略分析報告
- 2025-2030中國成人藝術(shù)培訓(xùn)行業(yè)發(fā)展格局及經(jīng)營效益預(yù)測報告
- 2026屆四川省宜賓市敘州區(qū)一中化學(xué)高二第一學(xué)期期末達標(biāo)檢測模擬試題含答案
- 寧夏石嘴山市一中2026屆化學(xué)高一第一學(xué)期期末經(jīng)典試題含解析
- 常德消防知識培訓(xùn)課件
- 2026屆湖北省武漢市青山區(qū)高三上化學(xué)期中質(zhì)量檢測模擬試題含解析
- 2025屆高中數(shù)學(xué)一輪復(fù)習(xí)講義:第六章 第1講 平面向量的概念及線性運算(含解析)
- 布料花藝基礎(chǔ)知識培訓(xùn)課件
- 2025年金屬非金屬礦山(露天礦山)安全管理人員模擬考試試題(附答案)
- 市政橋梁規(guī)范課件
- 電梯轉(zhuǎn)讓協(xié)議書范本
- 年產(chǎn)2000噸電子級超高純石英晶體材料制造項目環(huán)評報告表
- 2025年圣經(jīng)神學(xué)考試試題及答案
- 2025年佳木斯市郊區(qū)招聘公益性崗位人員(37人)筆試備考試題附答案詳解(基礎(chǔ)題)
- 基孔肯雅熱醫(yī)院感染防控
- 2025至2030年中國腳踏板總成市場現(xiàn)狀分析及前景預(yù)測報告
- 安徽省合肥一中2025屆高三5月回歸教材讀本
- 反向開票政策解讀課件
- 安徽國風(fēng)新材料股份有限公司招聘筆試題庫2024
- 庭院經(jīng)濟課件
- 完整版10kV配電線路運行維護規(guī)程
評論
0/150
提交評論